Source: International Congress 2018 – COPD management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Minakata (Wakayama, Japan), T. Motegi (Tokyo, Japan), J. Ueki (Chiba, Japan), Y. Gon (Tokyo, Japan), T. Seki (Tokyo, Japan), T. Anzai (Tokyo, Japan), S. Nakamura (Tokyo, Japan), K. Hirata (Osaka, Japan), M. Ichinose (Sendai, Japan). Efficacy of tiotropium/olodaterol on sedentary/active time in COPD patients: VESUTO study. 4390

Member's Comments

No comment yet.

Related content which might interest you: Efficacy and safety of erdosteine in COPD: Results of a 12-month prospective, multinational study Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Direct cost analysis of COPD patients: A 1 year follow-up study Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Compliance of pharmacotherapy with GOLD-guidelines: a longitudinal study in patients with COPD Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 Frequency of exacerbations in patients with COPD: an analysis of the SPIROMICS cohort Source: International Congress 2017 – COPD: latest insights into the management of patients Year: 2017 Osteoporosis onset in patients prescribed ICS for COPD: matched cohort study Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms Year: 2018 Persistence of clinical criteria of chronic bronchitis in patients with COPD over time: A longitudinal analysis of the TRACE cohort. Source: International Congress 2017 – Markers of COPD progression Year: 2017 Acute exacerbation of COPD patients therapy priorities: A survey study Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care Year: 2021 Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013 Tolerability and efficacy of budesonide/formoterol via Turbuhaler® vs standard treatment in Japanese patients with moderate to severe COPD: 52-week phase III study results Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012 Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 Baseline characteristics of patients admitted for the first time for COPD exacerbation. The ²phenotype and course of COPD² (PAC-COPD) study Source: Annual Congress 2007 - Epidemiology of COPD Year: 2007 Limitations for the inclusion of patients in the Roflu-2011 study Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 One-year efficacy of aclidinium/formoterol fixed-dose combination in COPD patients: The AUGMENT COPD study Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 Relationship between change in trough FEV1 and COPD patient outcomes: Pooled analysis of 23 clinical trials in patients with COPD Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 COPD patients´ perspectives at the time of diagnosis: a qualitative study Source: Eur Respir J 2006; 28: Suppl. 50, 740s Year: 2006 Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study Source: Eur Respir J, 50 (4) 1700711; 10.1183/13993003.00711-2017 Year: 2017 Exacerbations in a cohort of COPD patients: frequent exacerbators characteristics after 1-year follow-up (EXACO study – interim analysis) Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS) Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016 Bacterial profile and antibiotic susceptibility from patients with exacerbation of COPD: 10 – years prospective study Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 Adequacy of treatment in COPD patients referred to the emergency room for disease exacerbation: an Italian multicentre observational study (the COXER study) Source: Annual Congress 2008 - Management of COPD Year: 2008